新西兰 - 英文 - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - econazole nitrate 1%; zinc oxide 10% - topical paste - 1% /10% - active: econazole nitrate 1% zinc oxide 10%

新加坡 - 英文 - HSA (Health Sciences Authority)

sunward pharmaceutical private limited - econazole nitrate - cream - 1% w/w

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - econazole, quantity: 10 mg/g - solution - excipient ingredients: sorbitan monolaurate; purified water; benzyl alcohol; hydrochloric acid; peg-150 distearate; polysorbate 20; isopropyl alcohol; sodium chloride; sodium trideceth sulfate; sodium lauroamphoacetate; methylisothiazolinone; methylchloroisothiazolinone; magnesium nitrate; magnesium chloride hexahydrate - for the treatment of fungal skin infections such as pityriasis versicolor of the whole body, 'athlete's foot', 'ringworm' as well as other tinea and candidal complaints.

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

janssen-cilag ltd - econazole nitrate econazole nitrate -

纳米比亚 - 英文 - Namibia Medicines Regulatory Council

janssen pharmaceutica (pty) ltd - micronized econazole nitrate 150 mg - vaginal ovule - econazole nitrate 150 mg

马来西亚 - 英文 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

prime pharmaceutical sdn. bhd. - triamcinolone acetonide; econazole nitrate -

马来西亚 - 英文 - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

winwa medical sdn. bhd. - triamcinolone acetonide; econazole nitrate -

新西兰 - 英文 - Ministry for Primary Industries

virbac new zealand ltd - sulphur, econazole nitrate (unspecified), sodium thiosulphate, sodium salicylate, 2-phenoxyethanol, chloroxylenol - sulphur 19.4 g/litre; econazole nitrate (unspecified) 10 g/litre; sodium thiosulphate 75 g/litre; sodium salicylate 35 g/litre; 2-phenoxyethanol 13 g/litre; chloroxylenol 5 g/litre - antifungal

美国 - 英文 - NLM (National Library of Medicine)

mycovia pharmaceuticals, inc. - oteseconazole (unii: vhh774w97n) (oteseconazole - unii:vhh774w97n) - vivjoa is indicated to reduce the incidence of recurrent vulvovaginal candidiasis (rvvc) in females with a history of rvvc who are not of reproductive potential [see warnings and precautions (5.1), use in specific populations (8.3), and clinical studies (14)] . if specimens for fungal culture are obtained prior to therapy, antifungal therapy may be instituted before the results of the cultures are known. however, once these results become available, antifungal therapy should be adjusted accordingly. vivjoa is contraindicated in: - females of reproductive potential [see warnings and precautions (5.1) and use in specific populations (8.3)] - pregnant and lactating women [see warnings and precautions (5.1), and use in specific populations (8.1, 8.2)] - patients with known hypersensitivity to oteseconazole

新西兰 - 英文 - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - econazole 1%{relative};  ;   - topical solution - 1 % - active: econazole 1%{relative}     excipient: benzyl alcohol hydrochloric acid macrogol 6000 distearate miraspec tl/ldk polysorbate 20 purified water sorbitan laurate